Click here to get full coverage on Precigen Reports Third Quarter 2025 Financial Results and Business Updates - PR Newswire

Precigen Reports Third Quarter 2025 Financial Results and Business Updates  PR Newswire

Precigen Reports Third Quarter 2025 Financial Results and Business Updates - PR Newswire

Click here to get full coverage on Precigen Inc (PGEN) Q3 2025 Earnings Call Highlights: FDA Approval and U.S. ... - Yahoo Finance

Precigen Inc (PGEN) Q3 2025 Earnings Call Highlights: FDA Approval and U.S. ...  Yahoo Finance

Precigen Inc (PGEN) Q3 2025 Earnings Call Highlights: FDA Approval and U.S. ... - Yahoo Finance

Click here to get full coverage on Precigen (PGEN) Is Up 24.4% After FDA Approval and US Launch of Papzimeos – Has the Bull Case Changed? - simplywall.st

Precigen (PGEN) Is Up 24.4% After FDA Approval and US Launch of Papzimeos – Has the Bull Case Changed?  simplywall.st

Precigen (PGEN) Is Up 24.4% After FDA Approval and US Launch of Papzimeos – Has the Bull Case Changed? - simplywall.st

Click here to get full coverage on Precigen (PGEN) Q3 2025 Earnings Call Transcript - The Motley Fool

Precigen (PGEN) Q3 2025 Earnings Call Transcript  The Motley Fool

Precigen (PGEN) Q3 2025 Earnings Call Transcript - The Motley Fool

Click here to get full coverage on HC Wainwright & Co. Maintains Precigen (PGEN) Buy Recommendation - Nasdaq

HC Wainwright & Co. Maintains Precigen (PGEN) Buy Recommendation  Nasdaq

HC Wainwright & Co. Maintains Precigen (PGEN) Buy Recommendation - Nasdaq

Click here to get full coverage on $PGEN stock is up 27% today. Here's what we see in our data. - Quiver Quantitative

$PGEN stock is up 27% today. Here's what we see in our data.  Quiver Quantitative

$PGEN stock is up 27% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis - PR Newswire

Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis  PR Newswire

Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis - PR Newswire

Click here to get full coverage on A Look at Precigen (PGEN) Valuation Following FDA Approval of PAPZIMEOS for Recurrent Respiratory Papillomatosis - Yahoo Finance

A Look at Precigen (PGEN) Valuation Following FDA Approval of PAPZIMEOS for Recurrent Respiratory Papillomatosis  Yahoo Finance

A Look at Precigen (PGEN) Valuation Following FDA Approval of PAPZIMEOS for Recurrent Respiratory Papillomatosis - Yahoo Finance

Click here to get full coverage on Will Papzimeos FDA Approval and Major Buy Shift Precigen's (PGEN) Investment Narrative? - simplywall.st

Will Papzimeos FDA Approval and Major Buy Shift Precigen's (PGEN) Investment Narrative?  simplywall.st

Will Papzimeos FDA Approval and Major Buy Shift Precigen's (PGEN) Investment Narrative? - simplywall.st

Click here to get full coverage on Patient Capital Bets Big on Precigen (PGEN) By Acquiring 10.2 Million Shares - The Motley Fool

Patient Capital Bets Big on Precigen (PGEN) By Acquiring 10.2 Million Shares  The Motley Fool

Patient Capital Bets Big on Precigen (PGEN) By Acquiring 10.2 Million Shares - The Motley Fool

Click here to get full coverage on Insider Purchase: Director at $PGEN Buys 10,645 Shares - Quiver Quantitative

Insider Purchase: Director at $PGEN Buys 10,645 Shares  Quiver Quantitative

Insider Purchase: Director at $PGEN Buys 10,645 Shares - Quiver Quantitative

Click here to get full coverage on Precigen Announces Up to $125 Million Non-Dilutive Financing - PR Newswire

Precigen Announces Up to $125 Million Non-Dilutive Financing  PR Newswire

Precigen Announces Up to $125 Million Non-Dilutive Financing - PR Newswire

Click here to get full coverage on Precigen’s (PGEN) Papzimeos Push Sparks Multibagger Ascent, Boosted by Analyst Optimism - Yahoo Finance

Precigen’s (PGEN) Papzimeos Push Sparks Multibagger Ascent, Boosted by Analyst Optimism  Yahoo Finance

Precigen’s (PGEN) Papzimeos Push Sparks Multibagger Ascent, Boosted by Analyst Optimism - Yahoo Finance

Click here to get full coverage on H.C. Wainwright Remains Bullish on Precigen (PGEN) - Yahoo Finance

H.C. Wainwright Remains Bullish on Precigen (PGEN)  Yahoo Finance

H.C. Wainwright Remains Bullish on Precigen (PGEN) - Yahoo Finance

Click here to get full coverage on FDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025 - PR Newswire

FDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025  PR Newswire

FDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025 - PR Newswire

Click here to get full coverage on Precigen, Inc. (NASDAQ:PGEN): Is Breakeven Near? - Yahoo Finance

Precigen, Inc. (NASDAQ:PGEN): Is Breakeven Near?  Yahoo Finance

Precigen, Inc. (NASDAQ:PGEN): Is Breakeven Near? - Yahoo Finance

Click here to get full coverage on Precigen Reports Full Year 2024 Financial Results and Business Updates - PR Newswire

Precigen Reports Full Year 2024 Financial Results and Business Updates  PR Newswire

Precigen Reports Full Year 2024 Financial Results and Business Updates - PR Newswire

Click here to get full coverage on PGEN Stock Surges 144% in August on FDA Nod for Rare Lung Disease Drug - Yahoo Finance

PGEN Stock Surges 144% in August on FDA Nod for Rare Lung Disease Drug  Yahoo Finance

PGEN Stock Surges 144% in August on FDA Nod for Rare Lung Disease Drug - Yahoo Finance

Click here to get full coverage on Precigen (PGEN) Secures FDA Approval for Papillomatosis Treatment - Yahoo Finance

Precigen (PGEN) Secures FDA Approval for Papillomatosis Treatment  Yahoo Finance

Precigen (PGEN) Secures FDA Approval for Papillomatosis Treatment - Yahoo Finance

Click here to get full coverage on Insider Purchase: Chief Financial Officer of $PGEN Buys 2,932 Shares - Quiver Quantitative

Insider Purchase: Chief Financial Officer of $PGEN Buys 2,932 Shares  Quiver Quantitative

Insider Purchase: Chief Financial Officer of $PGEN Buys 2,932 Shares - Quiver Quantitative

Click here to get full coverage on A Fresh Look at Precigen (PGEN) Valuation Following Q3 Revenue Growth and Widened Net Loss - simplywall.st

A Fresh Look at Precigen (PGEN) Valuation Following Q3 Revenue Growth and Widened Net Loss  simplywall.st

A Fresh Look at Precigen (PGEN) Valuation Following Q3 Revenue Growth and Widened Net Loss - simplywall.st

Click here to get full coverage on $PGEN stock is up 12% today. Here's what we see in our data. - Quiver Quantitative

$PGEN stock is up 12% today. Here's what we see in our data.  Quiver Quantitative

$PGEN stock is up 12% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Precigen (NASDAQ: PGEN) schedules Nov. 13 4:30 PM ET conference call to review results - Stock Titan

Precigen (NASDAQ: PGEN) schedules Nov. 13 4:30 PM ET conference call to review results  Stock Titan

Precigen (NASDAQ: PGEN) schedules Nov. 13 4:30 PM ET conference call to review results - Stock Titan

Click here to get full coverage on Why Precigen, Inc. (PGEN) is Skyrocketing So Far in 2025 - Yahoo Finance

Why Precigen, Inc. (PGEN) is Skyrocketing So Far in 2025  Yahoo Finance

Why Precigen, Inc. (PGEN) is Skyrocketing So Far in 2025 - Yahoo Finance

Click here to get full coverage on US High Growth Tech Stocks to Watch in November 2025 - simplywall.st

US High Growth Tech Stocks to Watch in November 2025  simplywall.st

US High Growth Tech Stocks to Watch in November 2025 - simplywall.st

Click here to get full coverage on The Outlook For Precigen (NASDAQ:PGEN) - Seeking Alpha

The Outlook For Precigen (NASDAQ:PGEN)  Seeking Alpha

The Outlook For Precigen (NASDAQ:PGEN) - Seeking Alpha

Click here to get full coverage on Insider Sale: Director at $PGEN Sells 1,403,360 Shares | PGEN Stock News - Quiver Quantitative

Insider Sale: Director at $PGEN Sells 1,403,360 Shares | PGEN Stock News  Quiver Quantitative

Insider Sale: Director at $PGEN Sells 1,403,360 Shares | PGEN Stock News - Quiver Quantitative

Click here to get full coverage on New Analyst Forecast: $PGEN Given $8.5 Price Target - Quiver Quantitative

New Analyst Forecast: $PGEN Given $8.5 Price Target  Quiver Quantitative

New Analyst Forecast: $PGEN Given $8.5 Price Target - Quiver Quantitative

Click here to get full coverage on 83% of Complete Responders Ongoing at 36 Months — Precigen's PAPZIMEOS Shows Durable Responses - Stock Titan

83% of Complete Responders Ongoing at 36 Months — Precigen's PAPZIMEOS Shows Durable Responses  Stock Titan

83% of Complete Responders Ongoing at 36 Months — Precigen's PAPZIMEOS Shows Durable Responses - Stock Titan

Click here to get full coverage on Precigen: This Billion-Dollar Approval Is Still Undervalued (NASDAQ:PGEN) - Seeking Alpha

Precigen: This Billion-Dollar Approval Is Still Undervalued (NASDAQ:PGEN)  Seeking Alpha

Precigen: This Billion-Dollar Approval Is Still Undervalued (NASDAQ:PGEN) - Seeking Alpha

Click here to get full coverage on $PGEN stock is up 8% today. Here's what we see in our data. - Quiver Quantitative

$PGEN stock is up 8% today. Here's what we see in our data.  Quiver Quantitative

$PGEN stock is up 8% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Precigen, Inc. Stock (PGEN) Opinions on FDA Approval of Papzimeos | PGEN Stock News - Quiver Quantitative

Precigen, Inc. Stock (PGEN) Opinions on FDA Approval of Papzimeos | PGEN Stock News  Quiver Quantitative

Precigen, Inc. Stock (PGEN) Opinions on FDA Approval of Papzimeos | PGEN Stock News - Quiver Quantitative

Click here to get full coverage on Precigen (PGEN): HC Wainwright & Co. Adjusts Price Target to $9. - GuruFocus

Precigen (PGEN): HC Wainwright & Co. Adjusts Price Target to $9.  GuruFocus

Precigen (PGEN): HC Wainwright & Co. Adjusts Price Target to $9. - GuruFocus

Click here to get full coverage on $125M Non-Dilutive Deal: Precigen Secures Major Funding for Revolutionary HPV Immunotherapy Launch - Stock Titan

$125M Non-Dilutive Deal: Precigen Secures Major Funding for Revolutionary HPV Immunotherapy Launch  Stock Titan

$125M Non-Dilutive Deal: Precigen Secures Major Funding for Revolutionary HPV Immunotherapy Launch - Stock Titan

Click here to get full coverage on Precigen, Inc. (PGEN) Secures $125M to Accelerate PAPZIMEOS Commercialization - Yahoo Finance

Precigen, Inc. (PGEN) Secures $125M to Accelerate PAPZIMEOS Commercialization  Yahoo Finance

Precigen, Inc. (PGEN) Secures $125M to Accelerate PAPZIMEOS Commercialization - Yahoo Finance

Click here to get full coverage on First-Ever FDA Approved Therapy: Precigen Leadership to Detail Breakthrough RRP Treatment at Key Events - Stock Titan

First-Ever FDA Approved Therapy: Precigen Leadership to Detail Breakthrough RRP Treatment at Key Events  Stock Titan

First-Ever FDA Approved Therapy: Precigen Leadership to Detail Breakthrough RRP Treatment at Key Events - Stock Titan

Click here to get full coverage on PGEN’s Roller Coaster Ride: What’s Next?​ - StocksToTrade

PGEN’s Roller Coaster Ride: What’s Next?​  StocksToTrade

PGEN’s Roller Coaster Ride: What’s Next?​ - StocksToTrade

Click here to get full coverage on Precigen stock surges on FDA approval (update) (PGEN:NASDAQ) - Seeking Alpha

Precigen stock surges on FDA approval (update) (PGEN:NASDAQ)  Seeking Alpha

Precigen stock surges on FDA approval (update) (PGEN:NASDAQ) - Seeking Alpha

Click here to get full coverage on Precigen, Inc.'s (NASDAQ:PGEN) Profit Outlook - Yahoo Finance

Precigen, Inc.'s (NASDAQ:PGEN) Profit Outlook  Yahoo Finance

Precigen, Inc.'s (NASDAQ:PGEN) Profit Outlook - Yahoo Finance

Click here to get full coverage on Growth or Bubble? Decoding PGEN’s Rapid Rise - StocksToTrade

Growth or Bubble? Decoding PGEN’s Rapid Rise  StocksToTrade

Growth or Bubble? Decoding PGEN’s Rapid Rise - StocksToTrade

Click here to get full coverage on Decoding Precigen Inc (PGEN): A Strategic SWOT Insight - GuruFocus

Decoding Precigen Inc (PGEN): A Strategic SWOT Insight  GuruFocus

Decoding Precigen Inc (PGEN): A Strategic SWOT Insight - GuruFocus

Click here to get full coverage on Is Now The Right Time To Watch Precigen's Commercial Launch Story? - RTTNews

Is Now The Right Time To Watch Precigen's Commercial Launch Story?  RTTNews

Is Now The Right Time To Watch Precigen's Commercial Launch Story? - RTTNews

Click here to get full coverage on Precigen Stock Tumbles as Company Undertakes Massive Shares Sale - StocksToTrade

Precigen Stock Tumbles as Company Undertakes Massive Shares Sale  StocksToTrade

Precigen Stock Tumbles as Company Undertakes Massive Shares Sale - StocksToTrade

Click here to get full coverage on Precigen Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - simplywall.st

Precigen Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags  simplywall.st

Precigen Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - simplywall.st

Click here to get full coverage on Precigen Signs a Credit Facility Agreement Worth $125 Million to Support PAPZIMEOS - Yahoo Finance

Precigen Signs a Credit Facility Agreement Worth $125 Million to Support PAPZIMEOS  Yahoo Finance

Precigen Signs a Credit Facility Agreement Worth $125 Million to Support PAPZIMEOS - Yahoo Finance

Click here to get full coverage on PGEN’s Unexpected 9% Surge: What’s Behind It? - StocksToTrade

PGEN’s Unexpected 9% Surge: What’s Behind It?  StocksToTrade

PGEN’s Unexpected 9% Surge: What’s Behind It? - StocksToTrade

Click here to get full coverage on PGEN - Precigen Inc Latest Stock News & Market Updates - Stock Titan

PGEN - Precigen Inc Latest Stock News & Market Updates  Stock Titan

PGEN - Precigen Inc Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on JP Morgan Upgrades Precigen (PGEN) Rating to Neutral | PGEN Stoc - GuruFocus

JP Morgan Upgrades Precigen (PGEN) Rating to Neutral | PGEN Stoc  GuruFocus

JP Morgan Upgrades Precigen (PGEN) Rating to Neutral | PGEN Stoc - GuruFocus

Click here to get full coverage on Precigen: August Is Pivotal For This Biotech Innovator - Seeking Alpha

Precigen: August Is Pivotal For This Biotech Innovator  Seeking Alpha

Precigen: August Is Pivotal For This Biotech Innovator - Seeking Alpha

Click here to get full coverage on Is Precigen (PGEN) The Hot Biotech Stock Under $5? - Yahoo Finance

Is Precigen (PGEN) The Hot Biotech Stock Under $5?  Yahoo Finance

Is Precigen (PGEN) The Hot Biotech Stock Under $5? - Yahoo Finance

Click here to get full coverage on Precigen (PGEN) Analyst Rating Reiterated by HC Wainwright & Co. | PGEN Stock News - GuruFocus

Precigen (PGEN) Analyst Rating Reiterated by HC Wainwright & Co. | PGEN Stock News  GuruFocus

Precigen (PGEN) Analyst Rating Reiterated by HC Wainwright & Co. | PGEN Stock News - GuruFocus

Click here to get full coverage on Here’s What the Wall Street Thinks About Precigen (PGEN)’s PAPZIMEOS Approval - Insider Monkey

Here’s What the Wall Street Thinks About Precigen (PGEN)’s PAPZIMEOS Approval  Insider Monkey

Here’s What the Wall Street Thinks About Precigen (PGEN)’s PAPZIMEOS Approval - Insider Monkey

Click here to get full coverage on PGEN: HC Wainwright & Co. Raises Price Target to $8.50 with Buy Rating | PGEN Stock News - GuruFocus

PGEN: HC Wainwright & Co. Raises Price Target to $8.50 with Buy Rating | PGEN Stock News  GuruFocus

PGEN: HC Wainwright & Co. Raises Price Target to $8.50 with Buy Rating | PGEN Stock News - GuruFocus

Click here to get full coverage on Cantor Fitzgerald Reaffirms Overweight Rating on Precigen (PGEN) - Insider Monkey

Cantor Fitzgerald Reaffirms Overweight Rating on Precigen (PGEN)  Insider Monkey

Cantor Fitzgerald Reaffirms Overweight Rating on Precigen (PGEN) - Insider Monkey

Click here to get full coverage on Precigen shares jump after US FDA approves first therapy for rare respiratory disease - Reuters

Precigen shares jump after US FDA approves first therapy for rare respiratory disease  Reuters

Precigen shares jump after US FDA approves first therapy for rare respiratory disease - Reuters

Click here to get full coverage on Insider Sell: Jeffrey Kindler Sells 174,360 Shares of Precigen I - GuruFocus

Insider Sell: Jeffrey Kindler Sells 174,360 Shares of Precigen I  GuruFocus

Insider Sell: Jeffrey Kindler Sells 174,360 Shares of Precigen I - GuruFocus

Click here to get full coverage on Precigen Inc (PGEN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Seizing ... - Yahoo Finance

Precigen Inc (PGEN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Seizing ...  Yahoo Finance

Precigen Inc (PGEN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Seizing ... - Yahoo Finance

Click here to get full coverage on Precigen Stock (PGEN) Roars Over 60% Higher on FDA Green Light for Papzimeos Therapy - TipRanks

Precigen Stock (PGEN) Roars Over 60% Higher on FDA Green Light for Papzimeos Therapy  TipRanks

Precigen Stock (PGEN) Roars Over 60% Higher on FDA Green Light for Papzimeos Therapy - TipRanks

Click here to get full coverage on Precigen (PGEN) Showcases Promising Results for PAPZIMEOS in Tre - GuruFocus

Precigen (PGEN) Showcases Promising Results for PAPZIMEOS in Tre  GuruFocus

Precigen (PGEN) Showcases Promising Results for PAPZIMEOS in Tre - GuruFocus

Click here to get full coverage on Precigen, Inc. (PGEN) Just Flashed Golden Cross Signal: Do You Buy? - Zacks Investment Research

Precigen, Inc. (PGEN) Just Flashed Golden Cross Signal: Do You Buy?  Zacks Investment Research

Precigen, Inc. (PGEN) Just Flashed Golden Cross Signal: Do You Buy? - Zacks Investment Research

Click here to get full coverage on Analysts Are Bullish on Precigen Stock (PGEN) Amid Positive Pipeline Developments - TipRanks

Analysts Are Bullish on Precigen Stock (PGEN) Amid Positive Pipeline Developments  TipRanks

Analysts Are Bullish on Precigen Stock (PGEN) Amid Positive Pipeline Developments - TipRanks

Click here to get full coverage on PGEN Stock Surges More Than 40% in a Week: What's Driving the Rally? - Yahoo Finance

PGEN Stock Surges More Than 40% in a Week: What's Driving the Rally?  Yahoo Finance

PGEN Stock Surges More Than 40% in a Week: What's Driving the Rally? - Yahoo Finance

Click here to get full coverage on Notable Wednesday Option Activity: TTEC, UAL, PGEN - Nasdaq

Notable Wednesday Option Activity: TTEC, UAL, PGEN  Nasdaq

Notable Wednesday Option Activity: TTEC, UAL, PGEN - Nasdaq

Click here to get full coverage on Precigen: UltraCAR-T Development Brings Another Side Of Pipeline Advancement (PGEN) - Seeking Alpha

Precigen: UltraCAR-T Development Brings Another Side Of Pipeline Advancement (PGEN)  Seeking Alpha

Precigen: UltraCAR-T Development Brings Another Side Of Pipeline Advancement (PGEN) - Seeking Alpha

Click here to get full coverage on Precigen: Successful Proof Of Platform, But Cash Worries Remain (NASDAQ:PGEN) - Seeking Alpha

Precigen: Successful Proof Of Platform, But Cash Worries Remain (NASDAQ:PGEN)  Seeking Alpha

Precigen: Successful Proof Of Platform, But Cash Worries Remain (NASDAQ:PGEN) - Seeking Alpha

Click here to get full coverage on Further weakness as Precigen (NASDAQ:PGEN) drops 16% this week, taking five-year losses to 89% - simplywall.st

Further weakness as Precigen (NASDAQ:PGEN) drops 16% this week, taking five-year losses to 89%  simplywall.st

Further weakness as Precigen (NASDAQ:PGEN) drops 16% this week, taking five-year losses to 89% - simplywall.st

Click here to get full coverage on Precigen Announces Pricing of $30.0 Million Public Offering of Common Stock - PR Newswire

Precigen Announces Pricing of $30.0 Million Public Offering of Common Stock  PR Newswire

PGEN

Price Chart

Key Statistics

Technicals

About PGEN

Latest News

Precigen Reports Third Quarter 2025 Financial Results and Business Updates - PR Newswire

Precigen Inc (PGEN) Q3 2025 Earnings Call Highlights: FDA Approval and U.S. ... - Yahoo Finance

Precigen (PGEN) Is Up 24.4% After FDA Approval and US Launch of Papzimeos – Has the Bull Case Changed? - simplywall.st

Advanced Charts

Top Gainers

Top Losers